Relationship between aldose reductase enzyme and the signaling pathway of protein kinase C in the in vitro diabetic retinopathy model.
Protein kinase C (PKC) and aldose reductase (AR) enzyme activities are increased in diabetes and its complications such as retinopathy, nephropathy and neuropathy. However, the relationship between PKC and AR, and the underlying molecular mechanisms are still unclear. We aimed to evaluate the relationship between these two enzymes and clarify the underlying molecular mechanisms by the related signaling molecules. The effects of hyperglycemia and oxidative stress on AR and PKC enzymes and the signalling molecules such as nuclear factor-kappa B (NF-kB), inhibitor kappa B-alpha (IkB-α), total c-Jun, phospho c-Jun, stress-activated protein kinases (SAPK)/Jun amino-terminal kinases (JNK) were evaluated in human retinal pigment epithelial cells (ARPE-19). AR, PKC protein levels and related signalling molecules were increased with hyperglycemia and oxidative stress. AR inhibitor sorbinil decreased PKC expression and activity and all signalling molecules' protein levels. Increased AR expression during hyperglycemia and oxidative stress is found to be correlated with the increase in PKC expression and activity in both condition. Decreased expression and activity of PKC and the protein levels of related signaling molecules with the AR inhibitor sorbinil showed that AR enzyme may have a key role in the expression of PKC enzyme and oxidative stress during diabetes.